Stryker Q2 2025: net sales $6.0B +11.1%, adj EPS $3.13 +11.4%, raises FY guidance

STRYKER CORP

2025-Q2 EPS reported $3.98 revenue$11,888,000,000

Net sales $6.0B +11.1% reported (+10.2% organic); MedSurg/Neuro +17.3%, Orthopaedics +2.0% (ex-spinal +10.7%).
Reported EPS $2.29 +7.0%; adjusted EPS $3.13 +11.4%. Adj. operating margin 25.7% +110 bps.
FY 2025 guidance raised: organic sales growth 9.5-10.0%, adj EPS $13.40-$13.60.
Tariff impact estimated at ~$175M net, reflecting US-China reduction and proposed US-EU framework.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.